2.0
23. März 2011
Ehemaliger Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Good products and good pay plan. Nexavar is a great product although there is still alot of missed growth opportunity.
Kontras
Poor senior management, Berlex people don't understand the specialty pharmaceutical space very well. Bayer senior team was much more capable.